Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Denise Scots-Knight Insider Profile
4 Followers
Denise Scots-Knight, Chief Executive Officer at Mereo BioPharma, holds 1.05M shares in Mereo BioPharma (Ticker: GB:MPH), holds 560.41K shares in Mereo Biopharma Group Plc (Ticker: MREO). Most recently, Denise Scots-Knight ― shares of Mereo BioPharma on ― for an estimated value of ―.
Denise Scots-Knight Mereo BioPharma (MPH)Chief Executive Officer
Mereo BioPharma (MPH)
Chief Executive Officer
Ranked #22,450 out of 98,624 Corporate Insiders
Profitable Transactions
3 out of 8 Profitable Transactions
Average Return
+7.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Denise Scots-Knight's holdings
Insider Roles
Chief Executive Officer
Roles that Denise Scots-Knight holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 05, 2023 - Today
Return:+114.00%
The most profitable trade made by Denise Scots-Knight
Denise Scots-Knight's Trading History
Mereo BioPharma
―
―
―
£279.33K
Mereo Biopharma Group Plc
Nov 30, 2023
Chief Executive Officer
Informative Buy
294.00K
$1.54M
List of latest transactions for each holding click on a transaction to see Denise Scots-Knight's performance on stock
You May Also Like
Denise Scots-Knight insider profile FAQ
What is the percentage of profitable transactions made by Denise Scots-Knight?
The percentage of profitable transactions made by Denise Scots-Knight is 38%.
What is the average return per transaction made by Denise Scots-Knight?
The average return per transaction made by Denise Scots-Knight is 7.60%.
What stocks does Denise Scots-Knight hold?
Denise Scots-Knight holds: GB:MPH, MREO stocks.
What was Denise Scots-Knight’s latest transaction?
Denise Scots-Knight latest transaction was an Uninformative Buy of ―.
What was Denise Scots-Knight's most profitable transaction?
Denise Scots-Knight’s most profitable transaction was an Informative Buy of MREO stock on July 5, 2023. The return on the trade was 114.00%.
What is Denise Scots-Knight's role in Mereo BioPharma?
Denise Scots-Knight's role in Mereo BioPharma is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.